Dr Sophie Otter

  • MD(Res) MBBChir MRCP FRCR
  • Consultant Clinical Oncologist
  • Spoken languages English

Overview

Awards received

  • Patricia McGregor Travel Fellowships Fund, 2012
  • Distinction in MSc Oncology, 2014
  • ESTRO 37 Junior Brachytherapy Travel Grant, 2018
  • ESTRO 38 Junior Brachytherapy Travel Grant, 2019
  • Keith Durrant Memorial Fellowship, RCR, 2019

Clinical interests

Dr Otter has clinical interests in urological and colorectal cancers

Publication & affiliations

Journals

  • Otter S, Whittaker S, Chatterjee J, Stewart A. The Human Papillomavirus as a Common Pathogen in Head and Neck, Cervical and Anal Cancers. Clin Oncol (R Coll Radiol) 31:81-90, 2019
  • Otter S, Chatterjee J, Stewart A, Micheal A. The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer. Clin Oncol (R Coll Radiol) 31:834-843. 2019
  • Otter S, Stewart A, Devlin P. Modern Brachytherapy. Hematol Oncol Clin North Am. Dec;33(6):1011-1025, 2019

Book chapters

  • Otter S, Holloway, C, Devlin P, Stewart A. Clinical Applications of Brachytherapy-Low Dose Rate and Pulse Dose Rate (chapter 26). Perez & Brady’s Principles and Practice of Radiation Oncology. 7th edition. 2019
  • Otter S, Holloway C, O’Farrell D, Devlin D, Stewart A. Brachytherapy (chapter 20). Clinical Radiation Oncology. Gunderson and Tepper. 5th edition 2020.

Professional memberships

  • Fellow of the Royal College of Radiologists (RCR)
  • Member of the Royal College of Physicians (MRCP)
  • Member of the European Society of Therapeutic Radiation Oncology (ESTRO)